Say goodbye to cheap versions of Ozempic and Wegovy

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for bankruptcy.

There’s never a dull day in the world of weight-loss medication. This week brought new restrictions on compounded GLP-1 medication, the cheaper, copycat versions of brand-name drugs that telehealth companies like Hims & Hers and Noom had been offering. Other developments include news that GLP-1 pills are on the way, and that a bankruptcy filing by weight-loss giant WeightWatchers is imminent. Let’s dive in.